aTYR PHARMA INC — Director's Dealing 2019

Jul 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2019-06-28

Reporting Person: Gross Jane A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-28	Stock Option (right to buy)	$5.1296	A	2285	Acquired	2029-06-28	Common Stock (2285)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors.

F2: The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019.